Financial statements and reports
- INTERIM MANAGEMENT REPORT AS AT MARCH 31, 2025
- ANNUAL FINANCIAL REPORT 31/12/2024
- INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2024
- INTERIM MANAGEMENT REPORT 30/06/2024
- INTERIM MANAGMENT REPORT AS OF 31 MARCH 2024
- ANNUAL FINANCIAL REPORT 31/12/2023
- INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023
- INTERIM MANAGEMENT REPORT 30/06/2023
- INTERIM FINANCIAL REPORT MARCH 31 2023
- ANNUAL FINANCIAL REPORT 31/12/2022
- INTERIM MANAGEMENT REPORT 30/09/2022
- H1 FINANCIAL REPORT 30/06/2022
- INTERIM MANAGEMENT REPORT 31/03/2022
- ANNUAL FINANCIAL STATEMENTS 31/12/2021
- INTERIM MANAGEMENT REPORT 30/09/2021
- H1 FINANCIAL REPORT 30/06/2021
- INTERIM MANAGEMENT REPORT 31/03/2021
- ANNUAL FINANCIAL REPORT 31/12/2020
- CONSOLIDATED FINANCIAL REPORT 30/09/2020
- H1 FINANCIAL REPORT 30/06/2020
- PHARMANUTRA GROUP CONSOLIDATED FINANCIAL STATEMENTS 31/12/2019
- H1 FINANCIAL REPORT 30/06/2019
- PHARMANUTRA GROUP STATUTORY FINANCIAL STATEMENT 31/12/2018
- PHARMANUTRA GROUP CONSOLIDATED FINANCIAL STATEMENTS 31/12/2018
- H1 FINANCIAL STATEMENTS 30/06/2018
- STATUTORY FINANCIAL STATEMENTS 31/12/2017
- CONSOLIDATED FINANCIAL STATEMENTS 31/12/2017
- H1 FINANCIAL STATEMENTS 30/06/2017
- CONSOLIDATED FINANCIAL STATEMENTS 31/12/2016
- STATUTORY FINANCIAL STATEMENTS 31/12/2016
